Literature DB >> 10494348

Apolipoprotein E and the response of the brain to injury.

D I Graham1, K Horsburgh, J A Nicoll, G M Teasdale.   

Abstract

Apolipoprotein E (apoE) is an important part of the means by which lipids are transported in the nervous system. This transport system provides injured nerve cells, the cholesterol and phospholipids for the maintenance and repair of membranes, the growth of neurites, dendritic remodelling and synaptogenesis, and the effect of injury to the nervous system is now known in part to be modulated by the various isoforms of apoE. After the demonstration of an association between the apoE epsilon 4 and increased risk of subsequent development of both sporadic and late-onset form Alzheimer's disease, recent studies have provided additional evidence for the possibility that apoE may play an isoform-specific role in determining both the initial response and the subsequent consequences to acute brain injury. Further studies are required to better understand not only the response(s) of the nervous system to injury, but also the relationship between acute injury to the brain and the subsequent development of neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494348     DOI: 10.1007/978-3-7091-6391-7_15

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  16 in total

1.  The Apolipoprotein E Epsilon (epsilon) 4 Allele Is Important for Trauma-related Epilepsy.

Authors:  Cynthia L. Harden
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

2.  The distribution of apolipoprotein E alleles in Scottish perinatal deaths.

Authors:  J-C Becher; J W Keeling; N McIntosh; B Wyatt; J Bell
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

3.  Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.

Authors:  Kunal Thaker; Marilyn Chwa; Shari R Atilano; Pinar Coskun; Javier Cáceres-Del-Carpio; Nitin Udar; David S Boyer; S Michal Jazwinski; Michael V Miceli; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Neurobiol Dis       Date:  2016-04-22       Impact factor: 5.996

4.  Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage.

Authors:  Jinwei Pang; Yitian Chen; Li Kuai; Ping Yang; Jianhua Peng; Yue Wu; Yue Chen; Michael P Vitek; Ligang Chen; Xiaochuan Sun; Yong Jiang
Journal:  Transl Stroke Res       Date:  2016-10-31       Impact factor: 6.829

Review 5.  Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage.

Authors:  N A Martínez-González; C L M Sudlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08-22       Impact factor: 10.154

6.  ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children.

Authors:  R B Oriá; P D Patrick; M O B Oriá; B Lorntz; M R Thompson; O G R Azevedo; R N B Lobo; R F Pinkerton; R L Guerrant; A A M Lima
Journal:  Braz J Med Biol Res       Date:  2010-03       Impact factor: 2.590

Review 7.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

8.  Long term neuropsychological outcome after head injury: relation to APOE genotype.

Authors:  K Millar; J A R Nicoll; S Thornhill; G D Murray; G M Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

9.  Induction of apolipoprotein E after traumatic brain injury in forensic autopsy cases.

Authors:  Yoshiyuki Orihara; Ichiro Nakasono
Journal:  Int J Legal Med       Date:  2002-04       Impact factor: 2.686

Review 10.  Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Andrew F Ducruet; Paul R Gigante; Zachary L Hickman; Brad E Zacharia; Eric J Arias; Bartosz T Grobelny; Justin W Gorski; Stephan A Mayer; E Sander Connolly
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.